4th Annual 2016 Scientific Computing Days
Articles,  Blog

4th Annual 2016 Scientific Computing Days


[Music] Today is the first day of the FDA
Scientific Computing Days. It’s a two-day symposium where all of the divisions come
together and present some of their work where they use scientific computing to
solve some regulatory or scientific problems. This event is important because of the
opportunity it provides for scientists to communicate to each other and thereby
cross fertilize ideas. It’s just a phenomenal event both in terms
of the speakers, the keynote speakers, and in terms of the posters that are available
and then the opportunity for breakout sessions, which truly will provide an
opportunity for people to be able to maybe develop our collaborations, our sharing.
And by doing collaborations, you don’t have an additive efficiency — you have a
multiplicative efficiency. Every time, after every conference like
this, we start about five to ten different collaborations. Even if one out of ten
produces a significant result—for health care people, that’s great. Because that
person whose health is going to be impacted because of this communication is
going to be your child, your mother — somebody you love. So that’s why it is
important in science to get people connected. It’s a very rare thing when you have all
these scientists all in one room, in one area where you can get to meet them, you
can find out what they are doing, and share your experiences, as well as how we
could help each other. At this point, I’m going to tie back to my
title, which is like “How Can We As Regulators Skate Towards Where the Puck
Is Going?” It’s been a mantra that, you know, that some industry greats, really
creative thinkers like Steve Jobs — it was all predicated on this idea: We need to
understand the consumer. We need to understand the market. We need to
understand where it’s going. And we need to make products that are going to match
that. Kessler says patents not only describe a specific invention, you know,
what they’re doing and why they are doing it, but also it just broadly tells us, in
the industry’s own words, what they’re capable of, what they are working towards.
We can use it to understand trends and where the puck is going. I tied it all
back together. One of the things I’m also interested in
is the vendor booths, because it’s interesting to see what new technology
the vendors are able to bring to FDA to help us with our mission. I’m Dr. John Greene, I’m senior director
of bioinformatics for CSRA Incorporated. Today we are at the FDA Scientific
Computing Days, where we have a booth in hopes of being able to support FDA in
its regulatory mission. We have a white paper on precision medicine working with
cancer for the National Cancer Institute where we support one of the cancer
genomic cloud pilots that are currently running. We’re partnered with the
Institute for Systems Biology and Google. And it’s the kind of thing we’d like to
take forward into other agencies of the federal government, particularly within
HHS, where the bulk of our business is. My name is Karen Davenport and I’m from
Los Alamos National Laboratory. My name is Poe Li. I’m from Los Alamos National
Lab. We’re here to present EDGE Bioinformatics as a platform available to
biologists, microbiologists, who don’t have a lot of experience in
bioinformatics, but this is a platform that allows them to answer complex
questions with next generation sequencing data. I’m Patrick Johnson. I’m head of corporate
research at a French software company called Dassault Systemes. And we had the
pleasure to have our CEO doing the keynote. And the major idea I want to share with
you today is that the virtual world is the source of imagination. So we believe
that the future of extreme knowledge is experimentation in the virtual world.
Because that’s the shortest distance between human brain and the phenomena. It’s a fantastic forum for us first
because the networking with the people that are basically framing regulatory and
scientific regulatory domains and decisions for the years to come. And so
we feel very privileged to be part of the FDA Days, and we want to be part of
its mission. I would just encourage anybody that’s
either in an office setting doing science for FDA or scientific research, or just
applications that are scientific in nature to go ahead and attend and take a
look at the different things that FDA is doing. This is an invaluable event, because
without this, you really don’t have the opportunity to have at one spot in two
days a full spectrum of the kinds of work that’s going on in the other Centers.

Leave a Reply

Your email address will not be published. Required fields are marked *